Johnson & Johnson - stock earnings
JNJ Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2020Q3 | 3.6 billion USD | 21.1 billion USD |
2021Q1 | 1.7 billion USD | 22.5 billion USD |
2021Q2 | 6.2 billion USD | 22.3 billion USD |
2021Q3 | 6.3 billion USD | 23.3 billion USD |
2021Q4 | 3.7 billion USD | 23.3 billion USD |
JNJ Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2017 | 1.3 billion USD | 76.5 billion USD |
2018 | 15.3 billion USD | 81.6 billion USD |
2019 | 15.1 billion USD | 82.1 billion USD |
2021 | 14.7 billion USD | 82.6 billion USD |
JNJ
List: Champions
Price: 176.85USD
Dividend Yield: 2.49%
Forward Dividend Yield: 2.40%
Payout Ratio: 40.69%
Dividend Per Share: 4.24 USD
Earnings Per Share: 10.42 USD
P/E Ratio: 30.22
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers—General
Volume: 6.7 million
Ebitda: 2.9 billionMarket Capitalization: 450.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 61
DGR3: 5.78%
DGR5: 5.87%
DGR10: 6.42%
DGR20: 9.43%